Tissue concentrations of MPTP and MPP+ after administration of lethal and sublethal doses of MPTP to mice
- 31 December 1990
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 54 (2-3) , 253-262
- https://doi.org/10.1016/0378-4274(90)90192-o
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Oral versus parenteral efficacy of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine (MPTP): Differential effects on depletion of heart norepinephrine and of striatal dopamine in miceBiochemical Pharmacology, 1987
- The pharmacology of the parkinsonian syndrome producing neurotoxin MPTP (1–methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine) and structurally related compoundsMedicinal Research Reviews, 1986
- 1-methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodentLife Sciences, 1986
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Colorimetric assay for monoamine oxidase in tissues using peroxidase and 2,2′-azinodi(3-ethylbenzthiazoline-6-sulfonic acid) as chromogenAnalytical Biochemistry, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983